IL-8 is a novel marker for breast cancer

被引：0
|
作者：
C Chavey
A Freund
S Durand
G Lazennec
机构：
[1] INSERM U540,
来源：
Breast Cancer Research | / 7卷
关键词：
Breast Cancer; Breast Cancer Cell; Breast Cell; Invasion Potential; Cancer Management;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] IL-8 is a novel marker for breast cancer
    Chavey, C
    Freund, A
    Durand, S
    Lazennec, G
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S38 - S39
  • [2] Serum IL-8 and IL-12 levels in breast cancer
    Derin, Duygu
    Soydinc, Hilal Oguz
    Guney, Nese
    Tas, Faruk
    Camlica, Hakan
    Duranyildiz, Derya
    Yasasever, Vildan
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2007, 24 (02) : 163 - 168
  • [3] Serum IL-8 and IL-12 levels in breast cancer
    Duygu Derin
    Hilal Oguz Soydinc
    Nese Guney
    Faruk Tas
    Hakan Camlica
    Derya Duranyildiz
    Vildan Yasasever
    Erkan Topuz
    Medical Oncology, 2007, 24 : 163 - 168
  • [4] An immunohistochemical study of interleukin-8 (IL-8) in breast cancer
    Pires de Campos Zuccari, Debora Aparecida
    Leonel, Camila
    Castro, Rodrigo
    Gelaleti, Gabriela Bottaro
    Jardim, Bruna Victorasso
    Moscheta, Marina Gobbe
    Regiani, Vitor Rafael
    Ferreira, Livia Carvalho
    Lopes, Juliana Ramos
    Neto, Dalisio de Santi
    Esteves, Jose Luis
    ACTA HISTOCHEMICA, 2012, 114 (06) : 571 - 576
  • [5] Expression of the prognostic marker IL-8 correlates with the immune signature and epithelial-mesenchymal transition in breast cancer
    Liao, Huifeng
    Li, Huayan
    Song, Jin
    Chen, Hongye
    Si, Huiyan
    Dong, Junhua
    Wang, Jiandong
    Bai, Xue
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (03)
  • [6] Identification of IL-8 as a key factor in breast cancer invasion and angiogenesis
    Wang, SM
    Lin, Y
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 : S349 - S349
  • [7] Targeting IL-8 signalling to inhibit breast cancer stem cell activity
    Singh, Jagdeep K.
    Simoes, Bruno M.
    Clarke, Robert B.
    Bundred, Nigel J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (11) : 1235 - 1241
  • [8] Association of IL-8 genetic polymorphisms and breast cancer risk in a Chinese population.
    He, Yinzai
    Sun, Shengrong
    Liu, Yanheng
    Tian, Kun
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (18): : 7892 - 7898
  • [9] Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells
    Alraouji, Noura N.
    Aboussekhra, Abdelilah
    MOLECULAR CARCINOGENESIS, 2021, 60 (01) : 51 - 59
  • [10] IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients
    Ma, Yunfeng
    Ren, Yi
    Dai, Zhi-Jun
    Wu, Cai-Jun
    Ji, Yan-Hong
    Xu, Jiru
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03): : 421 - 426
12345